Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
입원한 COVID-19 환자의 개선에 대한 재조합 에리트로포이에틴의 효능 및 안전성 평가: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
48 hours
Adverse reaction
Adverse reactions
age
approved
Arm
Bandar Abbas
Blinding
block randomization
blood pressure
Care
checked
chronic lung disease
clinical
clinical symptom
clinical trial
clinical trials
Committee
company
comparator Patients
composite endpoint
control group
Controlled clinical trial
controls
Coronary heart disease
COVID-19
COVID-19 patient
COVID-19 patients
CRP
Deep vein
Deep vein thrombosis
diabetes
Diabetes Mellitus
Diastolic blood pressure
dissemination
distilled water
Efficacy and safety
element
End-stage renal disease
endogenous
enoxaparin
erythropoietin
ethics committee
evaluate
evaluate the effect
excluded
exclusion criteria
expected
Haemoglobin
Health
Health care
heart disease
hospitalised
hospitalised COVID-19 patients
Hypoxemia
immune system
infiltration
injection
intervals
Intervention
intervention group
investigator
Iran
Laboratory test
Laboratory tests
LDH
Liver disease
Local
Lung disease
lung field
lung infiltration
lymphocyte
Lymphocyte count
lymphopenia
Medical Science
Medical Sciences
medication
minute
number
objective
oral contraceptive
outcome
oxygen
oxygen partial pressure
oxygen saturation
parallel-group
partial pressure
participant
Patient
PCR
performed
pharmaceutical
Pharmaceutical Company
Phase 2
Placebo
positive
Prevent
principal investigator
protocol
randomised
randomised controlled trial
Randomized
Randomly
receive
recombinant erythropoietin
recruitment
Registered
registry
renal disease
reported
respiratory
respiratory rate
Sample size
saturation
severe COVID-19 symptom
severe COVID-19 symptoms
Side effect
Side effects
Standard
Standard of care
status
sterile water
Study protocol
subcutaneous injection
subject
supplementary material
Systolic blood pressure
tachypnea
technology
the ethics committee
thrombosis
title
Treatment protocol
treatment protocols
Trial registration
university
vital signs
water
water for injection
weakened immune system
website
[DOI] 10.1186/s13063-021-05363-w PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-021-05363-w PMC 바로가기 [Article Type] Letter